Vimarsana
Biggest News Aggregation in the World

Page 20 - Exact Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Sciences Corp Today - Breaking & Trending Today

Sell-Off in Cathie Wood's ARK Innovation Fund Reached 48% at Low Point Thursday - Vimarsana News

Sell-Off in Cathie Wood's ARK Innovation Fund Reached 48% at Low Point Thursday

At its low of the day on Thursday, ARK Innovation was down more than 48% from its February 2021 52-week high.

Sell-Off in Cathie Wood's ARK Innovation Fund Reached 48% at Low Point Thursday - Vimarsana News

Sell-Off in Cathie Wood's ARK Innovation Fund Reached 48% at Low Point Thursday

At its low of the day on Thursday, ARK Innovation was down more than 48% from its February 2021 52-week high.

EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock? - Vimarsana News

EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making - Vimarsana News

New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San...

New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making - Vimarsana News

New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San...